FDA approves new treatment for genetic coagulation disorder
On Dec. 18, the U.S. Food and Drug Administration (FDA) approved Tretten, Coagulation Factor XIII A-Subunit (Recombinant), the first recombinant product for use in…
Technology
FDA approves first generic versions of Cymbalta
On Dec. 11, the U.S. Food and Drug Administration (FDA) approved the first generic versions of Cymbalta (duloxetine delayed-release capsules). Read more.
FDA issues safety communication for HeartStart AEDs
On Nov. 25, the U.S. Food and Drug Administration (FDA) issued a safety communication stating that certain HeartStart automated external defibrillator (AED) devices made…
FDA approves medical device for epilepsy
The U.S. Food and Drug Administration (FDA) has approved a device to help reduce the frequency of seizures in epilepsy patients who have not…
Amazing apps: Space-age tools for clinicians
Health apps hold the promise of greater access to medical services, better monitoring of chronic conditions, and improved patient outcomes.
Nursing leaders hold the key to translating genomics into practice
A survey of attitudes, knowledge and genomic competency
FDA allows marketing of ‘next generation’ gene sequencing devices
On Nov. 19, the U.S. Food and Drug Administration (FDA) allowed marketing of four diagnostic devices that can be used for high throughput gene…
Study: Natural compound may block effects of methamphetamine
Researchers at the University of Missouri have found that resveratrol may block the effects of methamphetamine. Read more.
FDA approves extended-release, single-entity hydrocodone product
On Oct. 25, the U.S. Food and Drug Administration (FDA) approved Zohydro ER (hydrocodone bitartrate extended-release capsules) for the management of pain severe enough…
FDA approves Gazyva for chronic lymphocytic leukemia
On Nov. 1, the U.S. Food and Drug Administration (FDA) approved Gazyva (obinutuzumab) for use in combination with chlorambucil to treat patients with previously…
Technology, transformation, and the nursing workforce
Nursing informatics professionals are ready to lead the transformation to a technology-enabled healthcare environment.
Using technology to make evidence-based staffing assignments
Workforce-management software and operational integration help match the right nurse to the right patient at the right time.
FDA approves new treatment for genetic coagulation disorder
On Dec. 18, the U.S. Food and Drug Administration (FDA) approved Tretten, Coagulation Factor XIII A-Subunit (Recombinant), the first recombinant product for…
FDA approves first generic versions of Cymbalta
On Dec. 11, the U.S. Food and Drug Administration (FDA) approved the first generic versions of Cymbalta (duloxetine delayed-release capsules). Read more.
FDA issues safety communication for HeartStart AEDs
On Nov. 25, the U.S. Food and Drug Administration (FDA) issued a safety communication stating that certain HeartStart automated external defibrillator (AED)…
FDA approves medical device for epilepsy
The U.S. Food and Drug Administration (FDA) has approved a device to help reduce the frequency of seizures in epilepsy patients who…
Amazing apps: Space-age tools for clinicians
Health apps hold the promise of greater access to medical services, better monitoring of chronic conditions, and improved patient outcomes.
Nursing leaders hold the key to translating genomics into practice
A survey of attitudes, knowledge and genomic competency
FDA allows marketing of ‘next generation’ gene sequencing devices
On Nov. 19, the U.S. Food and Drug Administration (FDA) allowed marketing of four diagnostic devices that can be used for high…
Study: Natural compound may block effects of methamphetamine
Researchers at the University of Missouri have found that resveratrol may block the effects of methamphetamine. Read more.
FDA approves extended-release, single-entity hydrocodone product
On Oct. 25, the U.S. Food and Drug Administration (FDA) approved Zohydro ER (hydrocodone bitartrate extended-release capsules) for the management of pain…
FDA approves Gazyva for chronic lymphocytic leukemia
On Nov. 1, the U.S. Food and Drug Administration (FDA) approved Gazyva (obinutuzumab) for use in combination with chlorambucil to treat patients…
Technology, transformation, and the nursing workforce
Nursing informatics professionals are ready to lead the transformation to a technology-enabled healthcare environment.
Using technology to make evidence-based staffing assignments
Workforce-management software and operational integration help match the right nurse to the right patient at the right time.
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.